Abstract: In some embodiments, an electric field generator generates an electric field at a nominal frequency and a nominal amplitude. The electric field generator is connected to an antenna that radiates the electric field. A detector measures a frequency and an amplitude of the generated electric field as the electric field interacts with a body (such as a human body) in a reactive near-field region of the electric field. For each of one or more internal components of the body, a computation unit determines a respective periodic behavior in the measured frequency corresponding to movement of the internal component. The computation unit also computes, for each of the one or more internal components, a respective rate of the movement of the internal component based on the determined respective periodic behavior in the measured frequency. A gain control circuit adjusts the nominal amplitude according to the measured amplitude.

Abstract: In some embodiments, an electric field generator includes a differential oscillator that oscillates at a nominal frequency. The electric field generator is connected to a differential antenna that radiates an electric field. A differential detector measures a frequency of the generated electric field as the electric field interacts with a body (such as a human body) in a reactive near-field region of the electric field. For each of one or more internal components of the body, a computation unit determines a respective periodic behavior in the measured frequency indicative of movement of the internal component. The computation unit also computes, for each of the one or more internal components of the body, a respective rate of movement (such as a heart rate or a respiration rate) of the internal component according to the respective periodic behavior in the measured frequency.

Abstract: In some embodiments, an electric field generator generates an electric field at a nominal frequency. A detector measures, at multiple time points during a measuring period, one or more properties of the generated electric field. In various embodiments, the one or more properties of the electric field change over time due to interactions with a human body in a reactive near-field region of the electric field. From the measured one or more properties, a computation unit determines one or more periodic behaviors (such as a respiration or heartbeat) and one or more non-periodic behaviors (such as movement of a limb). The computation unit also computes, from at least one of the periodic and non-periodic behaviors, one or more physiological parameters of the human body. From the one or more physiological parameters, the computation unit detects one or more symptoms of a condition of the human body.

Abstract: A lighting system for a vertical farm can include a plurality of modules configured to be stacked and removably coupled physically and electrically to one another by at least one overhead robot. Each of the plurality of modules can include at least one physical and electrical connector. At least some of the modules can include one or more lighting elements.

Abstract: The invention relates to a nano-biohybrid organism (or nanorg) comprising one of at least seven different core-shell quantum dots (QDs) or gold nanoparticle clusters, with excitations ranging from ultraviolet to near-infrared energies, couple with targeted enzyme sites in bacteria. When illuminated by light, these QDs drive the renewable production of biofuel molecules and chemicals using carbon-dioxide (CO2), water, and nitrogen (from air) as substrates. Nanorgs catalyze light-induced air-water-CO2 reduction with a high turnover number (TON) of approximately 106-108 (mols of product per mol of cells) to biofuels such as isopropanol (IPA), butane diol, gasoline additives, gasoline substitutes, 2,3-butanediol (BDO), C11-C15 methyl ketones (MKs), and hydrogen (H2); Sand chemicals such as formic acid (FA), ammonia (NH3), ethylene (C2H4), and degradable bioplastics, e.g. polyhydroxybutyrate (PHB). These nanorg cells function as nano-microbial factories powered by light.

Abstract: An automatic vertical farming system may include a frame defining at least one growth area and configured to support a plurality of vertical plant growth structures within the at least one growth area. The system may include at least one robot disposed on a top side of the frame and movably supported by the frame. At least one robot may include at least one tool configured to manipulate the plurality of vertical plant growth structures. The system may include at least one infiltration chamber configured to contain at least one of the plurality of vertical plant growth structures and expose the vertical plant growth structure to an inoculant. The system may include a control system including at least one processor configured to automatically control operation of the at least one robot and the at least one infiltration chamber.

Abstract: A medical device for cutting substances inside a body lumen includes a flexible and elongated drive shaft including a distal portion and a proximal portion, a cutting member connected to the distal portion of the drive shaft to be rotatable with the drive shaft, and a hub located at the proximal portion and supporting the drive shaft, the hub including a first bearing mounted on the drive shaft and an elastic ring that is made of an elastic material on an outer periphery of the first bearing.

Abstract: A process for fractionating the constituents of a solution obtained by extracting plant or animal material with an aqueous-organic solvent where the aqueous-organic solvent is a mixture of water and a water-miscible organic solvent, generally including the steps of contacting the solution with a near-critical fluid to produce a raffinate phase containing high polarity constituents and water, and a near-critical fluid phase containing low to medium polarity constituents, separating the near-critical fluid phase from the raffinate phase, and recovering the low to medium polarity constituents from the near-critical fluid phase and the high polarity constituents from the raffinate phase.

Abstract: Processes for producing dairy products having lower levels of neutral lipids, and/or higher levels of polar lipids, by extraction using near critical carbon dioxide or dimethyl ether. These products may be used as ingredients in infant formulas. Infant formulas containing beta-serum are also claimed. “Beta-serum” means an aqueous dairy ingredient separated from dairy streams containing greater than 60% fat which have been through phase inversion from an oil-in-water to a water-in-oil emulsion, such as the serum produced during the production of butter oil.

Abstract: A process for obtaining lipids containing highly unsaturated fatty acids from plant or animal material, including contacting the material with liquid dimethyl ether to give a dimethyl ether solution containing lipids and a residue of plant or animal material, separating the solution from the residue of plant or animal material, and recovering lipids from the solution.

Abstract: A process for obtaining lipids containing highly unsaturated fatty acids from plant or animal material, including contacting the material with liquid dimethyl ether to give a dimethyl ether solution containing lipids and a residue of plant or animal material, separating the solution from the residue of plant or animal material, and recovering lipids from the solution.

Abstract: A process for fractionating the constituents of a solution obtained by extracting plant or animal material with an aqueous-organic solvent where the aqueous-organic solvent is a mixture of water and a water-miscible organic solvent, generally including the steps of contacting the solution with a near-critical fluid to produce a raffinate phase containing high polarity constituents and water, and a near-critical fluid phase containing low to medium polarity constituents, separating the near-critical fluid phase from the raffinate phase, and recovering the low to medium polarity constituents from the near-critical fluid phase and the high polarity constituents from the raffinate phase.

Abstract: A process for extracting a wide range of lipophilic compounds from urea-containing solutions is described. The process utilises a near-critical fluid as the extraction solvent. The process is particularly applicable to the extraction of polyunsaturated fatty acids from the filtrate obtained upon urea fractionation, as employed in the processing of fish and other oils. In contrast to known processes, the lipophilic compounds may be extracted without the use of non-food grade solvents, and are suitable for pharmaceutical and cosmetic use.

Abstract: Processes for producing dairy products having lower levels of neutral lipids, and/or higher levels of polar lipids, by extraction using near critical carbon dioxide or dimethyl ether. These products may be used as ingredients in infant formulas. Infant formulas containing beta-serum are also claimed. “Beta-serum” means an aqueous dairy ingredient separated from dairy streams containing greater than 60% fat which have been through phase inversion from an oil-in- water to a water-in-oil emulsion, such as the serum produced during the production of butter oil.

Abstract: An antenna for microwave tumor ablation provides coaxial antenna conductors surrounded by an insulated sleeve of length and size promoting destructive interference of axial microwave energy passing inside and outside of the sleeve to limit the tail of SAR power toward the skin.

Abstract: A reverse transcriptase encoded by L-1 (LINE-1) has been identified as a target molecule for treating or preventing cancers induced or mediated by this molecule. Method of treating or preventing such cancers in patients involves administration of a therapeutically effective amount of a composition having an inhibitor or antagonist of the reverse transcriptase in cells of the patients. The inhibitor or antagonist blocks lengthening of telomeres in telomerase negative cells. Methods and kits for detecting pathologically proliferating cells expressing L1RT are also disclosed.

Abstract: A drive transmission assembly for transmitting motive drive between a reciprocating drive member (11) and a driven member (16) in order to move the driven member (16) between first and second limits of reciprocal movement, the assembly including a drive transmission member (20) adapted for connection to the drive member (11) and the driven member (16) in order to transmit said motive drive, a fixed stop member (22) arranged to be located within the path of reciprocal travel of said transmission member (20), the transmission member (20) including a stop (25) for abutment with said stop member (22) in order to define said first or second limit of reciprocal movement for the driven member (16), said transmisson member (20) being adapted to define a vibration isolating connection between said stop (25) and said drive member (11), whilst said stop (25) is in abutment with said stop member (22).